Lilly Ventures Fund I LLC 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-06-08 4:04 pm Sale | 2020-05-11 | 13D | Protagonist Therapeutics, Inc. PTGX | Lilly Ventures Fund I LLC | 1,559,060 4.500% | -540,422 (-25.74%) | Filing |